Neuroendocrine carcinoma (NEC)israre. Wereport acase ofprobable sinonasal NEC in a 73-year-old man whohad presented with a historyof right nasalobstruction, nasal discharge, and recurrent epistaxis. On examination,a red, friable, gelatinous, polypoid masswith a tendency to bleed wasseen in the right nasal cavity. Computed tomography revealed that the lesion was confined to the right nasal cavity; coincidental or reactive opacification was seen in theadjacentsinuses. Thefinal histologic evaluation of the excised biopsyspecimens yieldedadiagnosis ofan invasive, poorly differentiated NEC, probably a large-cell variant, with thedifferential diagnosis lyingat a point somewhere between poorly differentiated large-cell NEC and highgrade olfactory neuroblastoma. The patient underwenta rightlateral rhinotomyand medialmaxillectomyjollowed by adjuvant radiotherapy. At 20 months offollow-up, he exhibited no sign of recurrence.
Introduction
Neuroendocrine carcinoma (NEe) was first proposed as a clinical entity by Silva et al in 1982. 1 It is a rare malignant neoplasm that contains neurosecretory granules and lacks a neurofibrillary background. NEC is classified as well-differentiated, intermediately differentiated, and poorlydifferentiated; poorly differentiated NECs are subclassified as small-cell, intermediate-cell, and large-cell. In this article, we describe a case of an invasive, poorly differentiated sino nasal NEC, probably a large-cell variant. 
Case report
A 73-year-old man presented with a 2-year history of right nasal obstruction with discharge and an 18-month history ofright nasal epistaxis. He denied anosmia, pain, tearing, and diplopia, and he did not exhibit a neck mass or proptosis. His medical history included hypertension and polymyalgia rheumatica; for the latter, he was on long-term steroid therapy. Examination revealed the presence of a red, friable, gelatinous, polypoid mass in the right nasal cavity. Findings on the remainder of the examination were unremarkable, and no cervical lymphadenopathy or cranial nerve palsies were identified. Findings on serologic testing-which included measurements of the complete blood count, renal function, liver function, and rheumatoid factor-were normal with the exception of a raised erythrocyte sedimentation rate of 26 mm/hr (range of normal: 1 to 12).
Examination under general anesthesia was performed, and a biopsy of the lesion was obtained. The examination revealed that the mass had arisen from the middle meatus and was attached to the middle turbinate. The lesion bled on contact. Computed tomography (CT) identified it as a soft-tissue mass that measured 2 to 3 cm in diameter. CT showed that the mass had expanded the right nasal cavity, a finding that suggested a chronic process rather than an invasivemalignant process (figure 1,A). Some associated opacification was seen in the right frontal sinus, the right ethmoid sinuses, the left anterior and middle ethmoid sinuses, and both maxillary antra (figure 1, B and C). There was no cribriform plate invasion or intracranial extension.
The provisional histology, based on multiple pieces of tissue measuring 4 x 3 x 1 cm , was inconclusive, and therefore a second histopathologic opinion was sought. The second opinion was that the specimens represented an invasive, poorly differentiated NEC, probably a large-cell variant, with the differential diagnosis lying at a point somewhere between poorly differentiated large-cell NEC and high-grade olfactory neuroblastoma. The biopsy specimens contained part
ENT-Ear, Nose & Throat Journal s May 2008
of an invasive, poorly differentiated malignant tumor that had infiltrated vascular turbinate tissue. No definitive neurophil, rosette/pseudorosette formation , or sustentacular pattern was seen on hematoxylin and eosin (H &E) staining (figure 2, A). There was also an absence of a central neurofibrillary matrix. The tumor cells expressed avid CD56, synaptophysin, and chro-mograninA immunoreactivity ( figure 2, B) . The result s of staining for cytokeratin (CK) 5/6, CK7,and epithelial membrane antigen were equivocal (figure 2, C ). Stains were negative for vimentin, S-100 protein, melan-A, HMB-45, carcinoembryonic antigen, CAM 5.2, broadspectrum cytokeratins, CK8/18/19 , and CK20.
The patient underwent a right lateral rhinotomy and medial maxillectomy; a lateral rhinotomy incision with a Lynch exten sion was used. Lateral flaps were dissected to the inferior orbitaL nerve, and a medial flap was elevated over the right nasal bone. Orbital perio steum was dissected and moved late rally. Th e maxillar y antrum was opened via the anterior wall with a gouge and hammer. An inferior incision was made though the inferio r meatus to the posterior wall of the antrum, and the medial one -third of the or bital floor was excised. The lacrimal duct was identified and tr ansected 1 em from the sac; th e sacrifice of the duct was necessary because of its proximity to the lateral edge of the tumor. A superior cut was made through the nasal bone toward the posterior aspect of the orbit, and the lateral wall was removed in a piecemeal fashion . The antrum was cleared. Anterior and posterior ethmoidectomies were carried out to clear the tumor. Diathermy, bone wax, and Surgicel were applied to achieve hemostasis.
The wound was closed and packed with aWhitehead's varni sh nasal pack. (Whitehead's varn ish is made up of a mixture of ethe r, iodoform, benzo in, sto rax, and tolu balsam . It is used for its antiseptic properties.) During the immediate postop erative period, the patient complained of diplopia secondary to extensive periorbital swelling; the diplopia subsided with conservative manageme nt. Two weeks postoperatively, th e Whitehead's pack was removed under general anesth esia, and th e patient received a cour se of adjuvant radiotherapy (55 Gy in 20 fractions over 1 month) delivered to the no se and paranasal sinuses.
Subsequ ent follow-up assessments were mad e with ant erior rhinoscopy and flexible nasendoscopy. At 20 months po stoperatively, the patient had shown no evidence of recurrence, and he had no complaints oth er than mild nasal cru sting. 
Figure 2, The tumor in nasal mucosa is seen on H&Estaining(A) and on immunohistochemistry with chromogranin A (B) and cytokeratin (C) (original magnification x20 for all slides),

Discussion
In th is case, th e final diagnosis of a prob able large-cell sino nasal NEC was based on th e tumor's appearance on light m icroscopy and its reactivity to immunohistochemical markers, In this way, we were able to distin guish sinonasal NEC from olfactory neuroblastoma 282· www.entjournal.com and sinonasal undifferentiated carcinoma; all three are neuroectoderma l tumors. These neuroectodermal tumors fall along a spectrum of disease:
• Olfactor y neuroblastoma is nonepithelial and the most differentiated of the neuroectoderma l tumors.
• Sinon asal undifferenti ated carcinoma is the least differentiated and has th e most tenu ou s neuroend ocrine qu alities.
• Sinon asal NEC lies along th e spectru m somewhere in between.'
NEC is considered to be a less differentiated version of olfactory neu rob lastom a because it has more epithelial carcinomatou s features. In two-thirds of all cases, sinonasal NEC stains for epithelial markers such as low-m olecular-weight cytokeratins and epithelial me mbra ne antigen. In contrast, olfactory neur oblastoma does not generally express epithelial markers.' However,both NEC an d olfactor y neurobl astom a share neuroendocrine tend encies, an d it has been postu lated that bot h arise from basal progenitor cells in th e olfactory mu cosa.I A neoplastic pro liferatio n of these cells is capable of developing int o either NEC or olfactory neuroblastoma. An association between olfactory neuroblastoma and asbestos has been postul ated.' Th is was not relevant to ou r case.
Both NEC and olfactory neurobl astoma exp ress ne uroendocrine m arkers such as syna ptophysin and chromogranin ,both of which were expressed in our case, as well as 5-100 protein, which was not. Beari ng in mind th at the pr esence of neuroendocrine m arker s m akes a diagnosis of sinonasal undifferenti ated carcinoma unlikely,th erewere specific findings in our case th at favored a diagno sis ofN EC over olfactory neuroblastom a. On e of these findin gs was th e absence of cribriform plate invasion. Also, olfactory neuroblastom a has a tend ency toward rosette for ma tion and a cent ral neurofibrillary ma trix, and these were absent in our patient . Anot her difference between the two is that NEC exhibits a diffuse pattern of 5-100 express ion, and olfactory neuroblastoma exhibits a sustentacular patterrr'<-but again, 5-100 protein was not expressed in this case.
Radiologically,sino nasal NEC and sino nasal un differentiated carcino ma are indistin guishable from olfactor y neuroblastom a.Both entities can appea r as an aggressive soft-tissue mass th at invades adjacent bon e rathe r th an remo deling it. Wit h sma ller sino nasal NECs, the mass is usually polypoid and confined to one nasal cavity, as occur red in our patien t. exhibited the classic constellation of symptoms, and both were successfully treated with complete surg ical excision.
As far as we know, our case of simultaneous bilateral first and second branchial cleft fistulas isonly the second ofits kind to be reported in the literature. The only other previously documented case was reported by Randall and Royster in 1963. 5 In terms of tumor site, most sinonasal NECs and sinonasal undifferentiated carcinomas occur in the same sites as do olfactor y neuroblastomas-that is, in the superior nasal cavity, the superior turbinate,and the ethmoid sinuses .Onlysinonasal NEC has been reported in the middle turbinate.'
There is clinical relevance in distinguishing between sinonasal NEC and olfactory neuroblastoma because the latter is typically more aggressiveand invasive.However, more cases need to be described and ana lyzed before we can make any significant comments on the differences in prognosis.
No meta-analysis has been published on th e optima l management of sinonasal NEC, but we do know th at treatment of allneuroectoderm al tu morssho uld include adequate resectio n margins and adjuvant rad iotherapy, which our patient received. For our patient, we chose an open approach for surgical resection because of the friable and bleeding nature of the tumor. The optimal management of olfactory neuroblastoma has been reported as a combination of surgical resection with adjuvant radiotherapy.' Resection can be accomplished via either an endoscopic or open approach. The role of chemotherapy and elective neck dissection remains unclear.
